Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Wave Life Sciences Ltd. - Ordinary Shares
(NQ:
WVE
)
5.765
+0.075 (+1.32%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Jun 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
765,484
Open
5.690
Bid (Size)
5.760 (1,700)
Ask (Size)
5.770 (1,700)
Prev. Close
5.690
Today's Range
5.645 - 5.775
52wk Range
5.020 - 21.73
Shares Outstanding
98,983,261
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wave Life Sciences to Present at Upcoming Investor Conferences
June 01, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter
↗
May 31, 2026
This clinical-stage biotech develops precision genetic medicines for neurological and hepatic disorders via its PRISM platform.
Via
The Motley Fool
Topics
Regulatory Compliance
Performance
YTD
-63.9%
-63.9%
1 Month
-22.8%
-22.8%
3 Month
-57.1%
-57.1%
6 Month
-17.5%
-17.5%
1 Year
-7.8%
-7.8%
More News
Read More
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences (NASDAQ:WVE) Beats Q1 Estimates as Obesity Program Accelerates
↗
April 28, 2026
Via
Chartmill
Wave (WVE) Q1 2026 Earnings Call Transcript
↗
April 29, 2026
Via
The Motley Fool
Topics
Earnings
Wave (WVE) Q2 2025 Earnings Call Transcript
↗
April 28, 2026
Via
The Motley Fool
Topics
Earnings
Wave (WVE) Q1 2025 Earnings Call Transcript
↗
April 28, 2026
Via
The Motley Fool
Topics
Earnings
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
April 28, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Leads Shift Toward Pipeline-Driven Valuation in Biotech Sector
April 22, 2026
Via
Investor Brand Network
Topics
Intellectual Property
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
April 22, 2026
Via
Investor Brand Network
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
April 22, 2026
From
BioMedWire
Via
GlobeNewswire
Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026
April 22, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States
April 21, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Proposed Redomiciliation to the United States
April 15, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Is This Weight Loss Drug Stock a Buy on the Dip?
↗
April 01, 2026
Via
The Motley Fool
Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
↗
March 26, 2026
Via
The Motley Fool
Topics
Stocks
Top movers analysis one hour before the close of the markets on 2026-03-26: top gainers and losers in today's session.
↗
March 26, 2026
Via
Chartmill
Here are the top movers in Thursday's session.
↗
March 26, 2026
Via
Chartmill
Thursday's session: gap up and gap down stocks
↗
March 26, 2026
Via
Chartmill
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
March 26, 2026
Via
MarketMinute
These stocks that are showing activity before the opening bell on Thursday.
↗
March 26, 2026
Via
Chartmill
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007
March 26, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
March 05, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Wave Life Sciences (WVE) Earnings Call Transcript
↗
February 27, 2026
Via
The Motley Fool
Topics
Earnings
Frequently Asked Questions
Is Wave Life Sciences Ltd. - Ordinary Shares publicly traded?
Yes, Wave Life Sciences Ltd. - Ordinary Shares is publicly traded.
What exchange does Wave Life Sciences Ltd. - Ordinary Shares trade on?
Wave Life Sciences Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares?
The ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares is WVE on the Nasdaq Stock Market
What is the current price of Wave Life Sciences Ltd. - Ordinary Shares?
The current price of Wave Life Sciences Ltd. - Ordinary Shares is 5.765
When was Wave Life Sciences Ltd. - Ordinary Shares last traded?
The last trade of Wave Life Sciences Ltd. - Ordinary Shares was at 06/03/26 11:00 AM ET
What is the market capitalization of Wave Life Sciences Ltd. - Ordinary Shares?
The market capitalization of Wave Life Sciences Ltd. - Ordinary Shares is 570.64M
How many shares of Wave Life Sciences Ltd. - Ordinary Shares are outstanding?
Wave Life Sciences Ltd. - Ordinary Shares has 571M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
